この記事の翻訳を準備しています。それまでの間、英語の原文を表示します。
ビジネス · 1999/7/221 分で読めます
Topical Antifungal Drug Products for Over-the-Counter Human Use; Proposed Amendment of Final Monograph
ローカル自動翻訳 · 情報源の原言語
概要
The Food and Drug Administration (FDA) is issuing a notice of proposed rulemaking that would amend the final monograph for over-the- counter (OTC) topical antifungal drug products. The amendment makes a minor change in the indications for these drug products. This proposal is part of the ongoing review of OTC drug products conducted by FDA.
情報源の原言語: Federal Register — Food and Drug Administration原文の発表を開く →